medmix AG (SW:MEDX) — Stock Price

CHF9.10 CHF
▼ -0.55% today

medmix AG (SW:MEDX) is currently trading at CHF9.10 CHF, down 0.55% today. Over the past 52 weeks, shares have ranged between CHF7.87 and CHF12.08. This page tracks medmix AG's live share price on the SW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MEDX market cap overview.

medmix AG (MEDX) Stock Price Chart — Daily History & Trading Volume

The chart below tracks medmix AG's daily closing share price and trading volume on the SW exchange over the past year, giving a clear view of recent price momentum and liquidity.

medmix AG Income Statement — Revenue, Profit & Earnings by Year

medmix AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CHF448.00 Million CHF483.90 Million CHF486.60 Million CHF477.10 Million CHF457.30 Million
Cost of Revenue CHF286.10 Million CHF324.20 Million CHF328.90 Million CHF301.70 Million CHF276.10 Million
Gross Profit CHF161.90 Million CHF159.70 Million CHF157.70 Million CHF175.40 Million CHF181.20 Million
Research & Development CHF19.60 Million CHF25.40 Million CHF25.70 Million CHF23.60 Million CHF23.00 Million
SG&A CHF114.90 Million CHF116.40 Million CHF119.00 Million CHF103.00 Million CHF95.60 Million
Total Operating Expenses CHF134.50 Million CHF146.80 Million CHF141.70 Million CHF155.80 Million CHF121.30 Million
Operating Income CHF27.40 Million CHF12.90 Million CHF16.00 Million CHF19.60 Million CHF59.90 Million
EBITDA CHF79.70 Million CHF67.60 Million CHF68.40 Million CHF68.30 Million CHF110.60 Million
EBIT CHF27.40 Million CHF6.00 Million CHF13.00 Million CHF18.70 Million CHF59.70 Million
Interest Expense CHF9.00 Million CHF11.80 Million CHF10.10 Million CHF6.50 Million CHF8.40 Million
Income Before Tax CHF9.00 Million CHF-6.30 Million CHF2.90 Million CHF12.20 Million CHF51.30 Million
Income Tax Expense CHF2.00 Million — CHF2.20 Million CHF600.00K CHF7.30 Million
Net Income CHF6.40 Million CHF-7.40 Million CHF300.00K CHF11.60 Million CHF44.00 Million

medmix AG Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes medmix AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CHF969.30 Million CHF954.20 Million CHF1.01 Billion CHF1.11 Billion CHF974.40 Million
Total Current Assets CHF265.30 Million CHF261.20 Million CHF308.10 Million CHF489.00 Million CHF339.70 Million
Cash & Equivalents CHF3.00 Million CHF2.30 Million CHF3.10 Million CHF208.10 Million CHF700.00K
Short-term Investments CHF8.40 Million — CHF-300.00K CHF3.30 Million CHF200.00K
Net Receivables CHF68.50 Million CHF46.80 Million CHF58.10 Million CHF62.00 Million CHF30.10 Million
Inventory CHF76.00 Million CHF75.40 Million CHF88.40 Million CHF91.80 Million CHF79.20 Million
Property, Plant & Equipment CHF269.00 Million CHF262.00 Million CHF258.10 Million CHF229.70 Million CHF229.50 Million
Goodwill CHF266.50 Million CHF271.60 Million CHF268.50 Million CHF254.40 Million CHF258.00 Million
Total Liabilities CHF536.50 Million CHF507.50 Million CHF532.40 Million CHF601.10 Million CHF440.50 Million
Total Current Liabilities CHF171.90 Million CHF162.90 Million CHF178.10 Million CHF271.10 Million CHF117.40 Million
Long-term Debt CHF249.10 Million CHF248.20 Million CHF247.30 Million CHF246.90 Million CHF238.90 Million
Net Debt CHF286.40 Million CHF227.20 Million CHF219.10 Million CHF160.00 Million CHF111.10 Million
Total Stockholder Equity CHF425.70 Million CHF436.40 Million CHF465.40 Million CHF504.80 Million CHF533.90 Million
Retained Earnings CHF495.70 Million CHF498.90 Million CHF529.80 Million CHF540.30 Million CHF552.80 Million

medmix AG Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how medmix AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CHF67.80 Million CHF86.60 Million CHF56.10 Million CHF47.60 Million CHF87.30 Million
Capital Expenditures CHF34.50 Million CHF48.50 Million CHF52.90 Million CHF38.60 Million CHF31.90 Million
Free Cash Flow CHF33.30 Million CHF38.10 Million CHF3.20 Million CHF9.00 Million CHF55.40 Million
Investing Cash Flow CHF-40.70 Million CHF-51.50 Million CHF-80.60 Million CHF-57.00 Million CHF-3.30 Million
Financing Cash Flow CHF-36.30 Million CHF-48.60 Million CHF-153.80 Million CHF116.10 Million CHF111.60 Million
Dividends Paid CHF-15.00 Million CHF-15.00 Million CHF-15.00 Million CHF15.00 Million CHF41.30 Million
Stock-Based Compensation CHF3.10 Million CHF4.40 Million CHF2.50 Million CHF4.80 Million CHF5.70 Million
Depreciation CHF52.30 Million CHF61.60 Million CHF55.40 Million CHF51.10 Million CHF51.70 Million
Change in Cash CHF-12.60 Million CHF-12.50 Million CHF-182.90 Million CHF103.70 Million CHF195.00 Million

medmix AG Earnings History — EPS Actual vs. Analyst Estimates

Track medmix AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 23, 2026 — — —
Feb 26, 2026 — — —
Jul 22, 2025 0.16 0.00 —
Feb 25, 2025 -0.33 0.00 —
Feb 22, 2023 -0.30 0.00 —
Aug 04, 2022 0.58 0.00 —
Feb 21, 2022 0.44 0.00 —
Aug 20, 2021 0.12 0.00 —